Carrie A. Adelman

4.4k citations
29 papers · 3.0k indexed · 2 hit papers · h-index 17
Topics
Prostate Cancer Treatment and Research (11 papers)PARP inhibition in cancer therapy (11 papers)DNA Repair Mechanisms (10 papers)

In The Last Decade

Carrie A. Adelman

29 papers receiving 3.0k citations

Hit Papers

Olaparib for Metastatic Castration-Resistant Prostate Cancer2020202620222024202020204008001.2k

Peers

Carrie A. Adelman
Comparison fields: 5 of 97
  • Molecular Biology 1.6k
  • Oncology 1.5k
  • Pulmonary and Respiratory Medicine 1.4k
  • Cancer Research 729
  • Genetics 372
Replace Oleg Schmidt‐Kittler with:
Oleg Schmidt‐Kittler United States
T. Khanh United States
Katherine Crosby United States
Magali Lacroix‐Triki France
Robert J.C. Slebos Netherlands
Rebecca Leary United States
Gisela Keller Germany
Torben F. Ørntoft Denmark
Mark A. Pershouse United States
Marco Gerlinger United Kingdom
Carrie A. Adelman relative to Oleg Schmidt‐Kittler United States Oleg Schmidt‐Kittler's profile →
Citations per field
00.5×4.9×
Oleg Schmidt‐Kittler · 1×
Citations per year

Countries citing papers authored by Carrie A. Adelman

Since Specialization
Citations

This map shows the geographic impact of Carrie A. Adelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carrie A. Adelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carrie A. Adelman more than expected).

Fields of papers citing papers by Carrie A. Adelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carrie A. Adelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carrie A. Adelman. The network helps show where Carrie A. Adelman may publish in the future.

Co-authorship network of co-authors of Carrie A. Adelman

This figure shows the co-authorship network connecting the top 25 collaborators of Carrie A. Adelman. A scholar is included among the top collaborators of Carrie A. Adelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carrie A. Adelman. Carrie A. Adelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 16
2 46
3
Olaparib for Metastatic Castration-Resistant Prostate Cancerbreakdown →
1397
4
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancerbreakdown →
474
5 7
6 10
7 32
8 4
9 4
10 44
11 75
12 150
13 17
14 236
15 6
16 14
17 95
18 69
19 7
20 81

About Carrie A. Adelman

Carrie A. Adelman is a scholar working on Cell Biology, Oncology and Cancer Research, having authored 29 papers that have together received 3.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (11 papers), PARP inhibition in cancer therapy (11 papers) and DNA Repair Mechanisms (10 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (729 citations) and Pulmonary and Respiratory Medicine (1.4k citations). Carrie A. Adelman has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Johann S. de Bono, Fred Saad, David Olmos, Joaquı́n Mateo, Jinyu Kang, Antoine Thiery-Vuillemin, Shahneen Sandhu, Neal D. Shore, Karim Fizazi and Neeraj Agarwal. Their work appears in journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026